Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bristol-Myers Squibb and Medical Engineering Corp.

This article was originally published in The Gray Sheet

Executive Summary

Named as defendants in a suit seeking class action status which alleges that the companies' silicone inflatable penile implants are "defective, prone to malfunction, and are unsafe for use in the human body," according to lawyers for the plaintiff. The suit, filed July 5 in federal court in Philadelphia, seeks damages and medical monitoring for patients who received the implants. In May, a similar case was filed in San Francisco against American Medical Systems and Pfizer regarding AMS silicone penile implants ("The Gray Sheet" May 23, p. 32)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT002548

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel